📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
55
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
34%
📜 Warrant Exercise
60%
• Massive warrant overhang: 39% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration
15%
• Score climbed 8 points (worsening)
💹 Market Data
Market Cap$627.58M
Shares Outstanding57.26M
Float28.06M
Cash$109.56M
Debt$479.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 24.1% shares (2025Q4 vs prior)
66 institutional holders · 33.93M shares
#1
RA CAPITAL MANAGEMENT, L.P.
11.29M shares
#2
ADAR1 Capital Management, LLC
2.86M shares
#3
MPM BIOIMPACT LLC
2.67M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.09M
Days to Cover2.1
% of Float7.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
8-K
8K EVENT
Apr 28, 2026
4
INSIDER TRANSACTION
Feb 27, 2026
4
INSIDER TRANSACTION
Feb 17, 2026
4
INSIDER TRANSACTION
Jan 08, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CLYM
📊 CLYM FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CLYM Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.